Dr Spratt on the Use of Radiation in Low– and High-Risk Prostate Cancer
Daniel Spratt, MD, discusses the use of radiation therapy in low- and high-risk prostate cancer.
Stay updated with breaking news from Vincentk Smith. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Daniel Spratt, MD, discusses the use of radiation therapy in low- and high-risk prostate cancer.
A high impact study led by Daniel Spratt, MD, Vincent K. Smith Chair in Radiation Oncology at University Hospitals Seidman Cancer Center demonstrates the safety
Improved toxicity, advanced technology, and novel techniques have helped increase the use of radiotherapy for the treatment of different subgroups of patients with prostate cancer.
Findings presented at the 2023 ASTRO Annual Meeting expand substantial body of evidence demonstrating Decipher Prostate test’s ability to help inform prostate cancer treatment...
A predictive artificial intelligence (AI) biomarker of androgen deprivation therapy (ADT) benefit in prostate cancer was validated in a recent study published in NEJM Evidence.